Elstar Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Elstar Therapeutics's estimated annual revenue is currently $9.8M per year.
- Elstar Therapeutics received $39.0M in venture funding in January 2018. 0
- Elstar Therapeutics's total funding is $39M.
Employee Data
- 00
Elstar Therapeutics's People
| Name | Title | Email/Phone |
|---|
Elstar Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Elstar Therapeutics?
Elstar Therapeutics brings a powerful new approach to generating multi-functional therapeutics with the potential to fulfill the promise of precision cancer immunotherapy and chart new directions in fighting immunological diseases. Armed with a platform that enables rapid production of multi-functional molecules effective in modulating a broad range of immunological processes, Elstar's goal is to develop new medicines for life-threatening cancers and serious inflammatory diseases. Our Universal Targeted Immunotherapy (UniTI) platform uniquely positions Elstar to overcome barriers that have previously blocked many promising immunotherapeutic approaches. Elstar Therapeutics was founded by the veteran protein and antibody engineer Andreas Loew together with Apple Tree Partners (www.appletreepartners.com), a healthcare-focused venture capital firm based in New York City.
keywords:N/A
$39M
Total Funding
N/A
Number of Employees
$9.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Elstar Therapeutics News
Prior to hopping on board to Atlas, Godec was the senior associate at Apple Tree Partners, involved in building Elstar Therapeutics, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $64.9M | 0 | N/A | $751.3M |
#2 | $12.9M | 0 | N/A | $163M |
#3 | $4.8M | 0 | N/A | N/A |
#4 | $33.3M | 0 | N/A | $15M |
#5 | $4.6M | 0 | N/A | $38M |
Elstar Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-01-04 | $39.0M | A | Apple Tree Partners | Article |